Process Development

Our focus in Process Development is on E. coli and Pichia production technology

Solutions for meeting Large-Scale Needs

With a roster of over 60 completed projects, Richter-Helm BioLogics possesses extensive experience in developing and optimizing processes for producing recombinant proteins, plasmid DNA, and vaccines.

Our focus is on E. coli and Pichia production technology. Whether the starting point is the cDNA sequence of your target molecule or a preliminary small-scale process, we reliably carry your project to fruition by implementing large-scale, GMP-compliant manufacture. Interdisciplinary teams comprising experts on process development, analytics, and large-volume production ensure smooth scale-up. Small-scale process characterization and validation support round out our capabilities.